Health Condition 1: null- Beta thalassemia patients who are already on deferasirox single daily regimen.
Conditions
Interventions
Intervention1: Deferasirox: Dose will be the same patient is already taking.
Frequency will be be made twice daily by spliting the dose what the patient is already taking.
Route will be oral.
Durat
Sponsors
Nissar moopan
Eligibility
Inclusion criteria
Inclusion criteria: All patients diagnosed with beta thalassemia and on regular blood transfusion receiving once daily deferasirox. 2)Serum ferritin > 1500 mcg/L. 3)All thalassemia patients who are not on regular IV chelation therapy (receiving IV chelation during every transfusion)
Exclusion criteria
Exclusion criteria: 1)All thalasemia patients who are on oral deferiprone therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To asess the response to intervetion by serial serum ferritin level assesment at 6 monthsTimepoint: To asess the response to intervetion by serial serum ferritin level assesment at 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To asess the response to intervetion by serial serum ferritin level assesment at 0,3 monthsTimepoint: To asess the response to intervetion by serial serum ferritin level assesment at 0,3 months | — |
Countries
India
Contacts
Public ContactDr Nissar moopan
Kmc
Outcome results
None listed